Search

Your search keyword '"Willrich, Maria Alice V."' showing total 202 results

Search Constraints

Start Over You searched for: Author "Willrich, Maria Alice V." Remove constraint Author: "Willrich, Maria Alice V."
202 results on '"Willrich, Maria Alice V."'

Search Results

4. Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation

8. Cerebrospinal fluid kappa free light chains in patients with tumefactive demyelination.

12. Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains.

15. List of contributors

19. Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation

21. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement

22. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis

24. Mo1522: MULTICENTER REAL-WORLD EXPERIENCE OF USTEKINUMAB TROUGH LEVELS AND ANTIBODIES IN CROHN’S DISEASE MAINTENANCE THERAPY

25. sj-pdf-6-msj-10.1177_13524585221134213 – Supplemental material for Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis

26. sj-pdf-2-msj-10.1177_13524585221134213 – Supplemental material for Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis

27. sj-pdf-19-msj-10.1177_13524585221134213 – Supplemental material for Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis

28. sj-pdf-8-msj-10.1177_13524585221134213 – Supplemental material for Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis

29. sj-pdf-9-msj-10.1177_13524585221134213 – Supplemental material for Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis

30. sj-pdf-7-msj-10.1177_13524585221134213 – Supplemental material for Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis

31. sj-pdf-4-msj-10.1177_13524585221134213 – Supplemental material for Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis

32. sj-pdf-3-msj-10.1177_13524585221134213 – Supplemental material for Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis

33. sj-pdf-5-msj-10.1177_13524585221134213 – Supplemental material for Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis

34. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.

35. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.

39. Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience

44. A Cross Sectional Evaluation of Light Chain N-Glycosylation By MASS-FIX in Plasma Cell Disorders

45. Determination of Relapse Risk By Complement Gene Variants after Eculizumab Discontinuation in Complement-Mediated Thrombotic Microangiopathy: A Retrospective Review

46. MASS-FIX for the Diagnosis of Plasma Cell Disorders: A Single Institution Experience of 4118 Patients

48. Performance of perpendicular drop versus tangent skimming gating of M-protein in proficiency testing challenges

49. Distinct Cutoff Values of Adalimumab Trough Levels Are Associated With Different Therapeutic Outcomes in Patients With Inflammatory Bowel Disease

Catalog

Books, media, physical & digital resources